Safinamide Mesylate is a selective monoamine oxidase B inhibitor primarily used as an add-on treatment for patients with Parkinson’s disease experiencing motor fluctuations. This pharmaceutical substance… Read more
Safinamide Mesylate is a selective monoamine oxidase B inhibitor primarily used as an add-on treatment for patients with Parkinson’s disease experiencing motor fluctuations. This pharmaceutical substance is often analyzed alongside its specific degradation products and metabolic derivatives to ensure therapeutic consistency. Our collection of Safinamide Mesylate related compounds includes high-quality reference standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled analogues. Pharmaceutical laboratories utilize these materials for rigorous impurity profiling, method validation, and routine quality control during the manufacturing process. By providing access to precise analytical standards and isotopically labelled internal standards, this category supports the development of reliable bioanalytical assays and the regulatory compliance of drug products throughout their lifecycle. These reference materials are critical tools for scientists seeking to characterize chemical purity and quantify trace-level impurities in complex drug substance and drug product matrices.